ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    strive anti-jcv
Previous Study | Return to List | Next Study

Observational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative Participants (STRIVE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01485003
Recruitment Status : Active, not recruiting
First Posted : December 5, 2011
Last Update Posted : October 17, 2017
Sponsor:
Information provided by (Responsible Party):
Biogen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : November 30, 2018
  Estimated Study Completion Date : November 30, 2018